KartikAnandMD

PubMed

• Pulmonary Immune-Related Adverse Events of PD-1 Versus PD-L1 Checkpoint Inhibitors: A Retrospective Review of Pharmacovigilance.
  Swaminathan, I., Ebinama, U., Sheshadri, A., Anand, K.> ;Journal of Immunotherapy and Precision Oncology. 2023 Nov 1
• 3 citations
  Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy.
  Kalyan R Chitturi, Ethan A Burns, Ibrahim N Muhsen, Kartik Anand, Barry H Trachtenberg> ;Current Oncology Reports. 2022 Apr 1
• 39 citations
  A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
  Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Ange...> ;Science Translational Medicine. 2021 Dec 15
• 100 citations
  Primary diffuse large B-cell lymphoma of the uterus: A SEER database analysis.
  Allyne Ensor, Cesar Gentille Sanchez, Joe Ensor, Kartik Anand> ;Medicine. 2021 Oct 8
• 9 citations
  Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown.
  Srinivasan Sanjay, Seo Wei Leo, Kah Guan Au Eong, Gitalisa Andayani Adriono, Kenneth C.S. Fong, Kartik Anand, Rumita S. Kadarisman, David B. Granet, Padmamalini Mahend...> ;Ophthalmic Epidemiology. 2021 Jun 24
• 19 citations
  A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractor...
  Kartik Anand, Polly A. Niravath, Tejal Patel, Joe Ensor, Angel Rodriguez, Toniva Boone, Stephen T. C. Wong, Jenny C. Chang> ;Clinical Breast Cancer. 2021 Jun 1
• 2 citations
  Cardiac Failure Because of Osimertinib.
  Kartik Anand, Joe Ensor> ;Journal of Clinical Oncology. 2021 Apr 23
• 16 citations
  Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management.
  Ethan Burns, Cesar Gentille, Barry H. Trachtenberg, Sai Ravi Pingali, Kartik Anand> ;Diseases. 2021 Mar 17
• 12 citations
  Hepatitis B Virus Reactivation in Cancer Patients Treated With Immune Checkpoint Inhibitors.
  Ethan Burns, Ibrahim N. Muhsen, Kartik Anand, Jiaqiong Xu, Godsfavour Umoru, Abeer Arain, Maen Abdelrahim> ;Journal of Immunotherapy. 2021 Apr 1
• 14 citations
  Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.
  Kartik Anand, Tejal Patel, Polly A. Niravath, Angel Rodriguez, Jorge Darcourt, Anna Belcheva, Toniva Boone, Joe Ensor, Jenny C. Chang> ;Scientific Reports. 2021 Jan 8
• Cardiac dysfunction due to Osimertinib.
  Kartik Anand> ;Lung Cancer. 2021 Mar 1
• 22 citations
  Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
  Kartik Anand, Thuy L. Phung, Eric H. Bernicker, Philip T. Cagle, Randall J. Olsen, Jessica S. Thomas> ;Clinical Lung Cancer. 2020 Sep 1
• 29 citations
  Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors.
  Kartik Anand, Geetanjali Sahu, Ethan Burns, Allyne Ensor, Joe Ensor, Sai Ravi Pingali, Vivek Subbiah, Swaminathan P. Iyer> ;ESMO Open. 2020 Aug 1
• Radiation therapy in primary mediastinal large B-cell lymphoma treated with DA-R-EPOCH.
  Cesar Gentille, Kartik Anand, Shraddha M. Dalwadi, Akshjot Puri, Andrew M. Farach, Sai Ravi Pingali> ;Clinical Case Reports. 2020 Jul 1
• 22 citations
  T-cell lymphoma secondary to checkpoint inhibitor therapy.
  Kartik Anand, Joe Ensor, Sai Ravi Pingali, Patrick Hwu, Madeleine Duvic, Stephen Chiang, Roberto N. Miranda, Youli Zu, Swaminathan P. Iyer> ;Journal for Immunotherapy of Cancer. 2020 Feb 1
• 2 citations
  Multiple myeloma with concurrent immune thrombocytopenic purpura.
  Humaira Sarfraz, Kartik Anand, Shujuan Liu, Shilpan S. Shah> ;Ecancermedicalscience. 2020 Feb 20
• 1 citations
  The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases
  Ethan Burns, Kartik Anand, Betty Chung, Shilpan S. Shah, Jasleen K. Randhawa, Sai Ravi Pingali> ;Ecancermedicalscience. 2020 Feb 17
• 19 citations
  Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.
  Kartik Anand, Ethan Burns, Joe Ensor, Lawrence Rice, Sai Ravi Pingali> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Jan 1
• 70 citations
  Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
  Kartik Anand, Joe Ensor, Barry H. Trachtenberg, Eric H. Bernicker> ;JACC. Cardiooncology. 2019 Dec 1
• 27 citations
  Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.
  Kartik Anand, Jason Roszik, Dan S. Gombos, Joshua Upshaw, Vanessa N. Sarli, Salyna Meas, Anthony Lucci, Carolyn S. Hall, Sapna Pradyuman Patel> ;Cancers. 2019 Jun 20
• 1 citations
  Macrophage Activation Syndrome Secondary to Underlying Sarcoidosis
  Saro Kasparian, Kartik Anand, Ethan Burns, Betty Chung, Sai Ravi Pingali> ;Cureus. 2019 Jun 18
• 5 citations
  Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
  Kartik Anand, Polly A. Niravath> ;Current Oncology Reports. 2019 Apr 17
• 4 citations
  Complete Response to R-EPOCH in Primary Cardiac Lymphoma.
  Kartik Anand, Sai Ravi Pingali, Barry H. Trachtenberg, Swaminathan P. Iyer> ;Case Reports in Hematology. 2019 Apr 10
• 1 citations
  Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeterminate potential.
  Kartik Anand, Praveen Kumar, Sai Ravi Pingali, Debananda Pati, Swaminathan P. Iyer> ;American Journal of Hematology. 2019 Mar 1
• 1 citations
  Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
  Ethan Burns, Kartik Anand, Gonzalo Acosta, Malcolm Irani, Betty Chung, Abhishek Maiti, Ibrahim F. Ibrahim, Lawrence Rice> ;Case Reports in Hematology. 2019 Feb 12
• Join now to see all

Journal Articles

• Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)  
  Kartik Anand, Joe Ensor, Barry Trachtenberg, Eric Bernicker, JACC-Cardiooncology

Abstracts/Posters

• Comparative Review of 30 Day Non-Relapse Mortality (NRM) in B-Cell Lymphomas Associated with Anti-CD19 Chimeric Antigen Receptor T-Cells (CAR-T) from FDA Database, Cli...
  Kartik Anand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS. 
  2019 ASCO Annual Meeting - 6/1/2019
• Osimertinib induced cardio-toxicity: A retrospective review of FDA adverse events reporting system (FAERS). 
  2019 ASCO Annual Meeting - 6/1/2019